Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA
INCHEON, South Korea, Sept. 22, 2021 /PRNewswire/ -- Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at the BioProcess International Conference (BPI 2021) to offer clients an integrated and seamless drug development solution resulting in accelerated timelines. Samsung Biologics introduced its CDO process platform, S-Cellerate(TM),...
The World Federation of Hemophilia (WFH), in collaboration with the New York University (NYU) Wagner Graduate School of Public Service, launches a new academic training program for bleeding disorder...
MONTREAL, Sept. 22, 2021 /PRNewswire/ -- Taught exclusively online by renowned experts in the field of advocacy and bleeding disorders, this unique 8-month course will equip WFH national member organization (NMO) advocates with the knowledge and tools necessary to advocate for increased access to care and treatment in their country. Graduates of this academic course will receive an executive training...
Asieris Appoints Dr. Alice Chen as Vice President, Discovery Biology and Head of Translational Research
SHANGHAI, Sept. 22, 2021 /PRNewswire/ -- Asieris Pharmaceuticals announced the appointment of Dr. Alice Chen as Vice President, Discovery Biology and Head of Translational Research with effect from September 20, 2021. She will report to Dr. Kevin Pan, Founder and CEO of Asieris. Alice has over 20 years of experience in the US pharmaceutical/biotech industry with a successful track...
New Therapy to Treat Advanced Small Cell Lung Cancer ZEPZELCA® (lurbinectedin) Approved in Singapore
Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20 years ZEPZELCA provisional approval represents an important advance for adult patients whose metastatic SCLC has progressed on or after platinum-based chemotherapy HSA and US FDA collaborated via 'Project Orbis' initiative to accelerate availability to...
Urotronic Inc., Announces Completion of the First Optilume(R) Procedure in Asia
The Optilume® Drug Coated Balloon is a novel, minimally invasive technology for the treatment of urethral stricture. MINNEAPOLIS, Sept. 22, 2021 /PRNewswire/ -- Urotronic, Inc., a Minnesota based medical device company, today announced the first Optilume® Drug Coated Balloon procedure for the treatment of urethral stricture, was successfully performed in Hong Kong by Clinical Assistant Professor, Dr. Wayne Lam of...
Dr. Ivan Puah Sees An Increasing Number Of Patients Seeking Liposuction Correction Surgeries In Singapore
SINGAPORE, Sept. 22, 2021 /PRNewswire/ -- Dr Ivan Puah, an MOH-accredited liposuction doctor and Medical Director of Amaris B. Clinic, has seen a surge of patients seeking correction on their previously done liposuction from other cosmetic surgery clinics. Liposuction is a surgical technique that can remove more than 90% localised subcutaneous fat, which is resistant to diet and exercise....
1cm “Lasso” Technique for Ankle Ligament Reconstruction, Co-developed by Dr James Wee from Oxford Orthopaedics
SINGAPORE, Sept. 22, 2021 /PRNewswire/ -- Ankle Ligament Reconstruction Ankle Ligament Reconstruction is the surgical treatment of ankle injuries or damaged ankle ligaments to restore stability and function. Ankle sprains make up about half of all sports-related injuries and also commonly occurs as a result of a fall from standing height or when walking or running on uneven surfaces....
Bactiguard completes a directed new share issue to AMF, raising approximately SEK 228 million
The board of directors of Bactiguard Holding AB (publ) ("Bactiguard") has resolved on a directed new share issue of 1,500,000 B shares at a price of SEK 152 per share, corresponding to approximately SEK 228 million. STOCKHOLM, Sept. 22, 2021 /PRNewswire/ -- The Board of Directors of Bactiguard has, based on the authorisation granted by the general meeting on...
LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.
LILLE, France, Sept. 22, 2021 /PRNewswire/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack® assisted system, the LUMESEAL® laser platform. Designed to enhance ease-of-use and to provide greater precision and control throughout the procedure, Lumeseal is announced as the...
Koji Tanabe, CEO of I Peace, Inc. honored by World Biz Magazine with “Top 100 Innovation CEO” Award
PALO ALTO, Calif., Sept. 22, 2021 /PRNewswire/ -- Koji Tanabe, Founder and CEO of I Peace, Inc. (https://www.ipeace.com ), has been selected by the judges of World Biz Magazine's annual awards to be a recipient of the "Top 100 Innovation CEO – 2021" (https://www.worldbizmagazine.net/ ). I Peace, Inc. is a Palo Alto-based biotech...
